CNTB241220P2500
- 0.00
- 0.000.00%
Connect Biopharma Newsroom
ADRs End Lower; Barinthus Biotherapeutics PLC Declines 30%
Express News | U.S.-Listed Shares of Chinese Firms Drop Premarket on Worries Over Growing U.S.-China Trade Tensions Under Trump Presidency
Express News | Connect Biopharma Holdings Ltd - Attovia Therapeutics Appoints Steven Chan as CFO
Express News | Attovia Therapeutics Appoints Chief Financial Officer
Goldman Sachs Raises China Economic Growth Forecasts
China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?
Today's Pre-Market Movers and Top Ratings | LI, BABA, NKE and More
Express News | Hedge Funds Are Pouring Into ETFs Focusing on Chinese Equities With $2.4 Billion Inflows
Express News | U.S.-Listed Chinese Stocks Surge in Overnight Trading Following Politburo's Commitment to Fiscal Support
US Listed-Chinese Stocks Surge Tuesday on Policy Boost, Who Is Leading the Way
Express News | U.S.-Listed Shares of Chinese Firms Jump Premarket After China Announces Stimulus Measures
Ixlayer Launches 'IxEngage' a Direct-to-Patient Platform for Biopharma
Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
Connect Biopharma Welcomes New Finance VP
Optimistic Buy Rating for Connect Biopharma: Strategic Partnerships and Regulatory Progress Fuel Potential for Rademikibart
Connect Biopharma Pivots to U.S. Market Strategy
Connect Biopharma GAAP EPS of $0.14, Revenue of $24.12M Beats by $3.12M
Express News | Connect Biopharma: Cash & Cash Equivalents of $110.2 Mln to Support Planned Ops Into at Least H1 2027
Press Release: Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Good Position To Deliver On Growth Plans